Nothing Special   »   [go: up one dir, main page]
Jump to content

AptarGroup

From Wikipedia, the free encyclopedia
AptarGroup, Inc.
Aptar
Company typePublic
IndustryPackaging and drug delivery devices
Founded1992; 32 years ago (1992)[1]
Headquarters
Crystal Lake, Illinois
,
U.S.
Key people
Stephan Tanda (CEO), Robert Kuhn (CFO), Shiela Vinczeller (CHRO)
Products
  • Spray pumps and valves
  • Metered-dose inhaler valves
  • Nasal spray systems
  • Dispensing closures
  • Elastomer components for injection devices
  • Active packaging
RevenueIncrease US$3.487 billion (2023)
Increase $404 million[2] (2023)
Increase $284 million[3] (2023)
Total assetsIncrease $4.451 billion[4] (2023)
Total equityIncrease US$2.321 billion[5] (2023)
Number of employees
13,800 (2023)[6]
Subsidiaries
  • Next Breath
  • Cohero Health
  • Gateway Analytical
  • SeaquistPerfect Dispensing
  • Seaquist Closures
  • CSP Technologies
  • Noble International
  • FusionPKG
  • Voluntis
  • WeiHai Hengyu Medical Products Co., Ltd.
  • Nanopharm
Websitehttps://www.aptar.com/

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices.[7][1] The group has manufacturing operations in 18 countries.[8]

History

[edit]

The company began as Werner Die & Stamping in Cary, Illinois, in 1946 and later incorporated as AptarGroup in 1992.[1][9] Aptar originally developed spray valves and pumps for consumer and household products. The company later began producing nasal administration and pulmonary drug delivery devices such as nasal spray systems and metered-dose inhaler valves.[9][10][11][12] Biotech and pharmaceutical companies use Aptar's different Unidose and Bidose devices for the single or two-shot intranasal delivery of different medicines.[13]

In 2016, Aptar announced that it provided the delivery system for Adapt Pharma's Narcan.[14] Narcan is a naloxone hydrochloride nasal spray used as an emergency treatment for opioid overdoses.[14] Aptar's liquid spray drug delivery technology platform works as a ready-to-use, single-shot, unit-dose system for Narcan. It was the first FDA approved nasally administered, ready-to-use medication used to reverse the effects of an opioid overdose.[14] Narcan does not require any assembly, medical training, or needle injection.[15]

In 2016, Aptar entered into an agreement with Becton Dickinson & Company to develop new self-injection devices.[16][17]

Aptar entered into an agreement in 2016 with Propeller Health Partners to develop a digitally connected medication inhaler.[18] The company made an investment in Propeller Health Partners (now part of Resmed) in 2018.[19]

In July 2019, the FDA-approved Aptar Pharma's Unidose Powder System as the first intranasally-delivered, needle-free rescue treatment for severe hypoglycemia.[13]

In 2020, during the COVID-19 pandemic, Aptar invested in new tools to accelerate its molding equipment and assembly machines for pumps, but it still wasn't enough to keep up with demand.[20]

Acquisitions

[edit]

In 2012, Aptar acquired Stelmi, a manufacturer of elastomer primary packaging components.[21] In 2016, Aptar acquired Mega Airless, a manufacturer of airless packaging solutions.[22] In 2018, Aptar acquired CSP Technologies, a material science company that manufactures active packaging solutions.[23]

In June 2019, Aptar acquired two companies, Nanopharm and Gateway Analytical.[24] In November 2019, the company acquired Noble International, which specializes in training devices and patient onboarding.[25] In February 2020, Aptar acquired FusionPKG, a makeup packaging company.[26][27]

In November 2020, the company acquired the digital respiratory health company Cohero Health.[28][29]

In July 2021 Aptar acquired the digital therapeutics company, Voluntis (ENXTPA: ALVTX), and 80% of the equity interests of Weihai Hengyu Medical Products Co., Ltd., a Chinese manufacturer of elastomeric and plastic components used in injectable drug delivery.[30]

Sustainability

[edit]

Aptar was named to Barron's list of the Top 100 Most Sustainable U.S. Companies in 2019, 2020, 2021, and 2022.[31][32][33][34] At the end of 2020, 85% of the company’s global electricity use came from renewable sources.[35] It was also named by Newsweek as one of America's Most Responsible Companies in 2021,[36] 2022,[37] and 2023[38] and received an A score for climate change from the Climate Disclosure Project.[39]

In September 2019, the company announced a partnership with Loop, a shopping platform from TerraCycle that delivers products in reusable containers.[40] The company made the Forbes Green Growth 50 List in 2021.[41]

References

[edit]
  1. ^ a b c "AptarGroup Inc". Bloomberg. Retrieved 2019-08-12.
  2. ^ "AptarGroup 10-K Filing 2023" (PDF).
  3. ^ "AptarGroup 10-K Filing 2023" (PDF).
  4. ^ "AptarGroup 10-K Filing 2023" (PDF).
  5. ^ "AptarGroup 10-K Filing 2023" (PDF).
  6. ^ "AptarGroup 10-K Filing 2023" (PDF).
  7. ^ "AptarGroup Inc". SEC. Retrieved 2019-08-12.
  8. ^ "Aptar Joins the World Business Council for Sustainable Development". World Business Council for Sustainable Development (WBCSD). 2019-02-05. Retrieved 2019-08-12.{{cite web}}: CS1 maint: url-status (link)
  9. ^ a b "History of AptarGroup, Inc. – FundingUniverse". Funding Universe. Retrieved 2019-08-12.
  10. ^ Mallory, Mike (2017-10-25). "Crystal Lake-based Aptar Pharma's opioid overdose reversal device goes nationwide". Northwest Herald. Archived from the original on 2017-10-26.
  11. ^ Strang, John; McDonald, Rebecca; Campbell, Gabrielle; Degenhardt, Louisa; Nielsen, Suzanne; Ritter, Alison; Dale, Ola (2019-09-01). "Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine". Drugs. 79 (13): 1395–1418. doi:10.1007/s40265-019-01154-5. ISSN 1179-1950. PMC 6728289. PMID 31352603.
  12. ^ "Aptar Pharma Provides Unit-Dose Nasal Spray Technology for Opioid Overdose". Drug Development and Delivery. 2016-05-20. Retrieved 2019-11-18.
  13. ^ a b "Aptar gets FDA approval for Unidose nasal drug delivery device". NS Medical Devices. 2019-07-26. Retrieved 2020-07-09.
  14. ^ a b c "Adapt Pharma's Nasal Spray Uses Unit-Dose Delivery System". Healthcare Packaging. 2016-05-19. Retrieved 2020-07-09.
  15. ^ "State health agency welcomes Narcan donations". AdVantage. 2018-02-08. Retrieved 2020-07-09.
  16. ^ Taylor, Phil (2016-09-13). "Aptar and BD join forces on auto-injector device". in-Pharma Technologist. Retrieved 2019-08-12.
  17. ^ Rahman, Lu (2016-09-02). "Aptar Pharma teams up with BD to develop novel auto-injector". EPM Magazine. Retrieved 2019-08-12.
  18. ^ Gormley, Brian (2016-02-25). "Propeller Health Joins With Aptar Pharma for Digitally Connected Medication Inhaler". Wall Street Journal. ISSN 0099-9660. Retrieved 2019-08-12.
  19. ^ Moukheiber, Zina. "With $20 Million In Funding, Propeller Health Partners With Aptar Pharma To Make Digital Medicines". Forbes. Retrieved 2019-08-12.
  20. ^ Chaudhuri, Saabira (2020-07-10). "Soap Makers Are Cleaning Up Amid the Pandemic, but Can't Get Enough Hand Pumps". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-07-17.
  21. ^ Taylor, Nick (2012-06-03). "Aptar to enter injectable device components with €165m buy". BioPharma Reporter. Retrieved 2019-08-12.
  22. ^ McDougall, Andrew (2016-02-02). "AptarGroup acquires Mega Airless for €200 million". Cosmetics Design. Retrieved 2019-08-12.
  23. ^ Johnson, Jim (2018-07-29). "AptarGroup buying CSP Technologies for $555 million". Plastics News. Retrieved 2019-08-12.
  24. ^ "Aptar acquires Nanopharm and Gateway Analytical". www.oindpnews.com. Retrieved 2021-07-17.
  25. ^ "Aptar acquires training device company Noble International". www.oindpnews.com. Retrieved 2021-07-28.
  26. ^ cosmeticsdesign.com (18 February 2020). "Aptar acquires makeup packaging company FusionPKG". cosmeticsdesign.com. Retrieved 2021-07-17.
  27. ^ "US company Aptar signs binding agreement to buy FusionPKG". www.packaging-gateway.com. 17 February 2020. Retrieved 2021-07-17.
  28. ^ "Cohero Health's digital respiratory assets get scooped up by AptarPharma". MobiHealthNews. 2020-11-05. Retrieved 2021-07-28.
  29. ^ "Aptar acquires Cohero Health". www.oindpnews.com. Retrieved 2021-07-28.
  30. ^ "Aptar Announces Exclusive Negotiations Regarding a Potential Acquisition of Voluntis to Expand in Digital Therapeutics". www.businesswire.com. 2021-06-22. Retrieved 2023-02-15.
  31. ^ Norton, Leslie P. (2019-02-08). "The 100 Most Sustainable U.S. Companies". Barrons. Retrieved 2019-08-12.
  32. ^ Norton, Leslie P. "These Are the 100 Most Sustainable Companies in America". www.barrons.com. Retrieved 2021-09-03.
  33. ^ Norton, Leslie P. "Here Are the 100 Most Sustainable Companies Right Now". www.barrons.com. Retrieved 2021-09-03.
  34. ^ "Aptar Named One of Barron's 100 Most Sustainable Companies in the U.S. for the Fourth Consecutive Year". Bloomberg.com. 2022-02-21. Retrieved 2022-06-27.
  35. ^ "These 10 Companies Are Leading on Environmental Impact". JUST Capital. Retrieved 2021-08-29.
  36. ^ Newsweek (2020-11-24). "America's Most Responsible Companies 2021". Newsweek. Retrieved 2021-08-27.
  37. ^ Newsweek (2021-12-02). "America's Most Responsible Companies 2022". Newsweek. Retrieved 2022-06-27.
  38. ^ Newsweek (2022-12-07). "America's Most Responsible Companies 2023". Newsweek. Retrieved 2023-01-19.
  39. ^ "A List companies". www.cdp.net. Retrieved 2021-08-27.
  40. ^ "Aptar Partners With TerraCycle's Loop Platform". Beauty Packaging. Retrieved 2021-08-05.
  41. ^ "Green Growth 50 2021". Forbes. Retrieved 2023-01-19.
Retrieved from "https://en.wikipedia.org/w/index.php?title=AptarGroup&oldid=1252273088"